Meta AnalysisID 3713
去甲肾上腺素对比米多君/奥曲肽在肝肾综合征-急性肾损伤患者中的疗效与安全性
CRD42021265989
PICOS: P (Participants): patients with hepatorenal syndrome-acute kidney injury; I (Interventions): ; Norepinephrine C (Comparisons): Midodrine/Octreotide; O (Outcomes): overall survival (OS), progression-free survival/d
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 3713
- Evidence Id
- 12271
- Core Evidence Id
- 12271
- Source Meta Analysis Id
- 3671
- Herb2 Meta Analysis Id
- HBMA003671
- Crd Id
- CRD42021265989
- Title
- The efficacy and safety of Norepinephrine versus Midodrine/Octreotide in patients with Hepatorenal Syndrome-Acute kidney injury.
- Review Question
- PICOS: P (Participants): patients with hepatorenal syndrome-acute kidney injury; I (Interventions): ; Norepinephrine C (Comparisons): Midodrine/Octreotide; O (Outcomes): overall survival (OS), progression-free survival/disease-free survival (PFS/DFS), improving renal function (return of serum creatinine to normal) and treatment-related adverse events; S (Study designs): Randomized controlled trials or observational studies
- Study Type Included
- Randomized controlled trials and Observational studies
- Condition Being Studied
- Hepatorenal Syndrome-Acute kidney injury.
- Participant
- Inclusion: Patients diagnosed as Hepatorenal Syndrome-Acute kidney injury. Exclusion: Patients who were not diagnosed as Hepatorenal Syndrome-Acute kidney injury.
- Animal
- Human Disease Modelled
- Intervention
- Norepinephrine
- Comparator Control
- Midodrine/Octreotide
- Main Outcome
- Overall survival (OS), progression-free survival/disease-free survival (PFS/DFS), improving renal function (return of serum creatinine to normal) and treatment-related adverse events. Measures of effect None
- Outcome Measure
- Additional Outcome
- None Measures of effect None
- Study Method
- Intervention, Meta-analysis, Network meta-analysis, Systematic review
- Keyword
- Acute Kidney Injury; Hepatorenal Syndrome; Humans; Midodrine; Norepinephrine; Octreotide
- Contact
- ISHFAQ RASHID [email protected]
- Organisational Affiliation
- NIPER Mohali India
- Funding Source
- Other Selection Criteria
- Final Publication
- Same Topic Review
- Published Protocol
- Review Type
- Language
- English
- Country
- India
- Review Stage
- Review Ongoing
- First Submission Date
- 2021-07-05
- Registration Date
- 2021-08-06
- Anticipated Start Date
- 2021-07-10
- Anticipated Completion Date
- 2021-08-20
- Title Cn
- 去甲肾上腺素对比米多君/奥曲肽在肝肾综合征-急性肾损伤患者中的疗效与安全性
- Title En
- The efficacy and safety of Norepinephrine versus Midodrine/Octreotide in patients with Hepatorenal Syndrome-Acute kidney injury.
- Bilingual Status
- complete